Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Cantab studies validate novel approach to treating IBD

Jan. 20, 1999

Eradication of H. pylori has dubious therapeutic effect in patients with nonulcer dyspepsia

Jan. 18, 1999

PAF antagonist safe but not effective in the treatment of ulcerative colitis

Jan. 13, 1999

Novel antiviral phenylpropenamide derivative for HBV

Jan. 12, 1999

Preclinical studies demonstrate mechanism of action, efficacy of anti-HBV agent

Jan. 12, 1999

Chinese authorities approve anti-HBV drug for marketing

Jan. 11, 1999

Sigma ligands synthesized at Jouveinal, evaluated and claimed for GI disorders

Jan. 8, 1999

Oxis announces initial results of phase IIa clinical trial in ulcerative colitis

Jan. 8, 1999

SciClone continues to receive and seek approvals for Zadaxin

Jan. 5, 1999

Antiulcer effects and mechanism of action of AU-006 explored

Jan. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...